Skip to main content
L

Not yet reviewed: this article is pending editorial review by Lyrea.

Citation noticeOur citation system is being overhauled

References and citation markers may currently be incomplete, mismatched, or incorrect. This system is being rebuilt and reviewed before the full site launch.

4-MeO-MiPT

4-MeO-MiPT molecule structure4-MeO-MiPT molecule structure
This article is a stubmissing:
Subjective Effects
Interactions
Tolerance
Harm Potential
Legality
4-Methoxy-N-methyl-N-isopropyltryptamine
Psychoactive Class
Chemical Class
Tryptamine

4-MeO-MiPT is a tryptamine with psychedelic effects in humans1 and member of the 4-methoxytryptamine family. First described in 1985 by David Repke, Alexander Shulgin, and colleagues, it is the 4-methoxy analogue of MiPT and an O-methyl ether of 4-HO-MiPT. Reports characterize it as relatively mild,2 with little or no visual effects reported after oral use,2 and describe it as a “little brother” of 5-MeO-MiPT.

Dosage & Duration

Dosage

Doses are population estimates that vary widely between individuals.

Threshold~10 mg
Light10 mg
Moderate10-20 mg
Strong20+ mg

Duration

Onset20-60 minutes
After Effects1-4 hours
Total3-7 hours

Subjective Effects

Subjective Effects not written up yet

Pharmacology

Pharmacodynamics

4-MeO-MiPT inhibits the serotonin transporter, increasing extracellular serotonin, and acts as a non-selective serotonin receptor agonist. It shows agonist activity at the 5-HT1A and 5-HT2A1 and, in a G-protein assay, 5-HT2C1 receptors. In rodents, it induces the head-twitch response1, a behavioral proxy of psychedelic activity.

Pharmacokinetics

Absorption & half-lifenot documented yetMetabolitesnone documented yet

Interactions

Interactions not written up yet

An unlisted combination is an unknown one, not a safe one. Check a dedicated combination chart before mixing.

Check TripSit

Tolerance

Tolerance not written up yet

Harm Potential

Harm Potential not written up yet

History & Culture

4-MeO-MiPT was first described in the scientific literature by David Repke, Alexander Shulgin, and colleagues in 1985. Alexander Shulgin later described it in greater detail as entry #39 in his 1997 book TiHKAL. A 2016 study analyzed 4-MeO-MiPT among new synthetic tryptamines purchased from an Internet shop3.

Legality

Legality not written up yet

Article Status

  • Josie Kins avatar
    Step 1 · Automated synthesis

    An autonomous workflow built by Josie Kins compiled this article's foundation from information published across the web.

  • Step 2 · First-pass reviewPending

    Not yet reviewed: this article is pending editorial review by Lyrea.

  • Step 3 · Citation reviewPending

    No one has reviewed this article's citations yet. That second pass checks each claim against the source it cites.

Suggest an edit

Spotted a mistake, an outdated claim, or something missing from the 4-MeO-MiPT article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.

Wish to give generalised feedback? You can do so here.